诺和诺德:诺和控股165亿美元收购康泰伦特的所有监管交割条件均已满足

界面
15 Dec 2024

当地时间12月14日,诺和诺德宣布,其大股东诺和控股以165亿美元收购美国合同制药商康泰伦特(Catalent)相关的所有监管交割条件均已满足,双方现在可自由完成交易,以及诺和诺德随后从诺和控股收购三个康泰伦特制造基地。诺和诺德预计收购将在未来几天完成。今年2月,诺和控股宣布,将以全现金交易形式收购康泰伦特,加上债务的企业总价值达到165亿美元。作为交易的一部分,诺和诺德将以110亿美元的预付款...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10